Switching from Concerta 36mg to Adderall XR
You can switch directly from Concerta 36mg to Adderall XR without a washout period, starting at 10-15mg of Adderall XR once daily in the morning, with close monitoring for efficacy and tolerability over the first 1-2 weeks.
Rationale for Direct Switching
Both methylphenidate (Concerta) and amphetamine (Adderall XR) are first-line stimulants for ADHD, and switching between stimulant families is common clinical practice 1. Research shows that 41% of medication-naive adults with ADHD require switching from their initial stimulant family to the alternative one within 90 days due to poor tolerability, indicating this is a routine clinical scenario 2.
- No washout period is required when switching between stimulant classes, as there are no significant drug-drug interactions between methylphenidate and amphetamines 1.
- The FDA labeling for Concerta does not mandate a taper or washout when discontinuing 3.
Dose Conversion Strategy
Start conservatively with Adderall XR 10-15mg once daily, as there is no precise dose equivalence between methylphenidate and amphetamine formulations 1.
- Concerta 36mg delivers approximately 12mg of immediate-release methylphenidate equivalent initially, with extended coverage 3.
- Adderall XR 10-15mg provides a reasonable starting point that balances efficacy with tolerability 1, 4.
- Do not attempt a 1:1 mg conversion, as amphetamines are generally more potent per milligram than methylphenidate 1.
Implementation Protocol
Day 1 of Switch:
- Stop Concerta 36mg completely 3.
- Start Adderall XR 10-15mg in the morning with or without food 1.
- Monitor vital signs (blood pressure and heart rate) at baseline and after 1-2 weeks, as cardiovascular response can predict treatment efficacy 5, 6.
Week 1-2 Monitoring:
- Assess for symptom control (attention, hyperactivity, impulsivity) 1.
- Monitor for adverse effects including appetite suppression, insomnia, irritability, anxiety, or cardiovascular changes 1, 6.
- Greater increases in blood pressure during initial amphetamine administration may predict better long-term response 5.
Dose Titration (if needed):
- If inadequate response after 1 week, increase Adderall XR by 5-10mg increments weekly 1.
- Typical effective dose range for Adderall XR is 10-30mg daily, though some patients require up to 40mg 1.
- Titrate based on clinical response and tolerability, not arbitrary dose equivalence 1.
Key Clinical Considerations
Why the Switch May Be Indicated:
- Inadequate efficacy despite optimal methylphenidate dosing (Concerta up to 72mg/day) 1, 3.
- Poor tolerability of methylphenidate (side effects preventing dose optimization) 2, 7.
- Wearing-off effects with Concerta's 12-hour duration requiring additional coverage 7.
- Patient preference for once-daily dosing with different duration characteristics 4.
Common Pitfalls to Avoid:
- Do not start at excessively high Adderall XR doses (≥20mg) in stimulant-experienced patients, as amphetamines have different tolerability profiles than methylphenidate 2, 6.
- Do not assume treatment failure if the first amphetamine dose is ineffective—adequate trial requires 2-4 weeks at therapeutic doses 1.
- Do not overlook adherence issues, comorbid conditions, or psychosocial factors that may have contributed to methylphenidate "failure" 7.
- Monitor for psychiatric adverse effects including anxiety, agitation, or mood changes, which may differ from methylphenidate's profile 6.
Predicting Response:
- Baseline characteristics poorly predict which stimulant family will work best 2.
- Patients who switched from methylphenidate showed more impairment on intrusive symptoms, but this had unclear clinical significance 2.
- Trial-and-error remains the standard approach, as precision psychiatry tools are not yet available 7.
Alternative Considerations
If the patient fails both methylphenidate and amphetamine trials at adequate doses and durations: